ATE356208T1 - Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein - Google Patents
Regulation des menschliches lipoxin a4 rezeptor- ähnliches proteinInfo
- Publication number
- ATE356208T1 ATE356208T1 AT01925421T AT01925421T ATE356208T1 AT E356208 T1 ATE356208 T1 AT E356208T1 AT 01925421 T AT01925421 T AT 01925421T AT 01925421 T AT01925421 T AT 01925421T AT E356208 T1 ATE356208 T1 AT E356208T1
- Authority
- AT
- Austria
- Prior art keywords
- receptor
- protein
- regulation
- lipoxin
- human lipoxin
- Prior art date
Links
- 101000818552 Mus musculus Formyl peptide receptor 2 Proteins 0.000 title abstract 2
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 206010047139 Vasoconstriction Diseases 0.000 abstract 1
- 230000002052 anaphylactic effect Effects 0.000 abstract 1
- 230000023597 hemostasis Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- IXAQOQZEOGMIQS-SSQFXEBMSA-M lipoxin A4(1-) Chemical compound CCCCC[C@H](O)\C=C\C=C/C=C/C=C/[C@@H](O)[C@@H](O)CCCC([O-])=O IXAQOQZEOGMIQS-SSQFXEBMSA-M 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
- 230000025033 vasoconstriction Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18903700P | 2000-03-14 | 2000-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE356208T1 true ATE356208T1 (de) | 2007-03-15 |
Family
ID=22695650
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01925421T ATE356208T1 (de) | 2000-03-14 | 2001-03-12 | Regulation des menschliches lipoxin a4 rezeptor- ähnliches protein |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20020058259A1 (de) |
| EP (1) | EP1266005B1 (de) |
| AT (1) | ATE356208T1 (de) |
| AU (1) | AU2001252181A1 (de) |
| DE (1) | DE60127102T2 (de) |
| ES (1) | ES2283403T3 (de) |
| WO (1) | WO2001068839A2 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU784543B2 (en) * | 1999-11-16 | 2006-04-27 | Pharmacia & Upjohn Company | Novel G protein-coupled receptors |
| US20040038862A1 (en) * | 2001-07-30 | 2004-02-26 | Goodwin Bryan James | Identification of new therapeutic targets for modulating bile acid synthesis |
| GB0119928D0 (en) * | 2001-08-15 | 2001-10-10 | Pfizer Ltd | New use |
| AU2003218716A1 (en) * | 2002-03-22 | 2003-10-08 | Bayer Aktiengesellschaft | Diagnostics and therapeutics for diseases associated with homo sapiens formyl peptide receptor-like 2 |
| AU2003214249A1 (en) * | 2002-04-03 | 2003-10-13 | Bayer Aktiengesellschaft | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) |
| WO2003093816A2 (en) * | 2002-05-02 | 2003-11-13 | Bayer Healtchare Ag | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) |
| US10154977B2 (en) * | 2011-03-25 | 2018-12-18 | The Brigham And Women's Hospital, Inc. | Anti-inflammatory particles |
| EP2597160B1 (de) | 2011-11-23 | 2015-09-23 | Universita' Degli Studi "G. d'Annunzio" Chieti-Pescara | Untersuchungsinstrument für die Entdeckung von entzündungshemmenden Arzneimitteln mit einem FPR2/ALX-Gen-Promoter |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000022131A2 (en) * | 1998-10-13 | 2000-04-20 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human g protein-coupled receptors |
| WO2000026339A2 (en) * | 1998-11-03 | 2000-05-11 | Smithkline Beecham Corporation | Axor14, a g-protein coupled receptor |
| KR20080104062A (ko) * | 1998-11-20 | 2008-11-28 | 아레나 파마슈티칼스, 인크. | 사람의 오르판 ｇ 단백질 커플링 수용체 |
| DE19930512A1 (de) * | 1999-07-05 | 2001-01-11 | Michael Brues | NFORMYL: gen, cDNA, Expression und Aminosäuresequenz |
| GB9924960D0 (en) * | 1999-10-21 | 1999-12-22 | Pfizer Ltd | Novel polypeptide |
| AU784543B2 (en) * | 1999-11-16 | 2006-04-27 | Pharmacia & Upjohn Company | Novel G protein-coupled receptors |
| US20040224314A1 (en) * | 1999-12-10 | 2004-11-11 | Neil Burford | G-protein coupled receptors |
-
2001
- 2001-03-12 AT AT01925421T patent/ATE356208T1/de not_active IP Right Cessation
- 2001-03-12 WO PCT/EP2001/002729 patent/WO2001068839A2/en not_active Ceased
- 2001-03-12 DE DE60127102T patent/DE60127102T2/de not_active Expired - Lifetime
- 2001-03-12 EP EP01925421A patent/EP1266005B1/de not_active Expired - Lifetime
- 2001-03-12 ES ES01925421T patent/ES2283403T3/es not_active Expired - Lifetime
- 2001-03-12 AU AU2001252181A patent/AU2001252181A1/en not_active Abandoned
- 2001-03-14 US US09/805,467 patent/US20020058259A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1266005B1 (de) | 2007-03-07 |
| ES2283403T3 (es) | 2007-11-01 |
| WO2001068839A3 (en) | 2002-03-28 |
| DE60127102T2 (de) | 2007-08-23 |
| EP1266005A2 (de) | 2002-12-18 |
| WO2001068839A2 (en) | 2001-09-20 |
| WO2001068839A9 (en) | 2002-07-18 |
| AU2001252181A1 (en) | 2001-09-24 |
| DE60127102D1 (de) | 2007-04-19 |
| US20020058259A1 (en) | 2002-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200701036A1 (ru) | Лактамные соединения и их применение в качестве фармацевтических препаратов | |
| DE60322339D1 (de) | Bindungsproteine als biosensoren | |
| WO2004034988A3 (en) | Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors | |
| EA201000245A1 (ru) | Человеческие нейтрализующие антитела к фактору роста нервов (ngf) в качестве селективных ингибиторов метаболического пути ngf | |
| EA200700118A1 (ru) | Амидосоединения и их применение в качестве лекарственных средств | |
| NO20043245L (no) | Bindingsproteiner som biosensorer | |
| ATE497783T1 (de) | Gerinnungsfaktor vii-fc chimäre proteine zur behandlung von hämostatischen krankheiten | |
| NZ592973A (en) | Compositions and methods of using angiopoietin-like 4 protein | |
| BR0011838A (pt) | Elementos misturadores estáticos empilhados | |
| HUP0301877A2 (hu) | Aromatáz inhibitorok és monoklonális anti-HER2 ellenanyagok mint tumorellenes szerek | |
| WO2003002114A3 (en) | Use of potent, selective and non toxic c-kit inhibitors for treating mastocytosis | |
| WO2004047728A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2004039956A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| AU2000233235A1 (en) | Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase | |
| EP1855719A4 (de) | Neutralisierende monoklonale antikörper gegen coronaviren in zusammenhang mit schwerem akutem atemwegssyndrom | |
| DE60127102D1 (de) | Regulation des menschliches lipoxin a4 rezeptor-ähnliches protein | |
| DE60313434D1 (de) | Verfahren und zusammensetzungen zur behandlung von hyperproliferativen zuständen | |
| WO2003002108A3 (en) | Use of tyrosine kinase inhibitors for treating inflammatory diseases | |
| DK1401413T3 (da) | Anvendelse af tyrosinkinaseinhibitorer til behandling af allergiske sygdomme | |
| DE60215648D1 (de) | Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen | |
| DE69934096D1 (de) | Zusammensetzungen und methoden zur wundheilung | |
| WO2001042431A3 (en) | Regulation of human mitochondrial deformylase | |
| DE60209886D1 (de) | Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen | |
| DE60113535D1 (de) | Kompositionen und verwendungen von cgi-69 | |
| WO2001072334A3 (en) | Methods for treating disease with antibodies to cxcr3 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |